tiprankstipranks
Phibro Animal Health (PAHC)
NASDAQ:PAHC
US Market
Holding PAHC?
Track your performance easily

Phibro Animal Health (PAHC) Earnings Dates, Call Summary & Reports

74 Followers

Earnings Data

Report Date
Feb 05, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
0.43
Last Year’s EPS
0.33
Same Quarter Last Year
Moderate Sell
Based on 2 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 06, 2018
|
% Change Since: -9.83%
|
Next Earnings Date:Aug 27, 2018
Earnings Call Sentiment|Positive
The earnings call reflects a strong start to the year with significant growth across various segments, especially in the Animal Health and Performance Products segments. The successful acquisition of Zoetis' Medicated Feed Additive business is seen as a key strategic move, anticipated to drive future growth despite transition-related impacts. Despite challenges such as increased SG&A expenses and the discontinuation of a product line, the overall outlook remains positive with increased guidance for fiscal year 2025.
Company Guidance
During the Phibro Animal Health Corporation's Q1 2025 earnings call, significant guidance metrics were provided for the fiscal year ending June 30, 2025. The company anticipates mid-single-digit revenue growth on a stand-alone basis, projecting net sales between $1.050 billion and $1.1 billion, with a midpoint growth of approximately 6%. Adjusted EBITDA is expected to range from $124 million to $132 million, reflecting growth of 11% to 19%. Adjusted net income is forecasted to be between $55 million and $60 million, representing a 14% to 24% increase. Additionally, Phibro expects the Zoetis Medicated Feed Additive portfolio, acquired recently, to contribute approximately $200 million in net sales, with an adjusted EBITDA margin of 20% and an adjusted EPS impact of $0.25 for the 8-month period in fiscal year 2025. The company also highlighted the ongoing benefits and onetime costs associated with its Phibro Forward initiative, which aims to drive further revenue growth and cost savings.
Strong Animal Health Business Growth
Animal Health business grew sales by 14% in the quarter, led by vaccines growth of 22% and MFA and other growth of 15%.
Performance Products Segment Growth
Performance Products segment grew by 27%, driven by increased demand for ingredients used in personal care products.
Increased Guidance for Fiscal Year 2025
Updated guidance for fiscal year 2025 shows expected mid-single-digit growth in revenue and a leveraged P&L on a stand-alone basis.
Successful Acquisition of Zoetis' Medicated Feed Additive Business
The acquisition closed successfully, and preliminary estimates for the Zoetis portfolio for the 8-month period in fiscal year 2025 include net sales of approximately $200 million with an adjusted EBITDA margin of approximately 20%.
Strong Financial Performance
First quarter adjusted EBITDA increased by $12 million or 64% versus the prior year, reflecting significant growth in adjusted net income and adjusted diluted EPS.
---

Phibro Animal Health (PAHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

PAHC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 27, 20182018 (Q4)
- / 0.46
0.3917.95% (+0.07)
Nov 06, 20182019 (Q1)
- / 0.39
0.382.63% (+0.01)
Feb 06, 20192019 (Q2)
- / 0.41
0.437-6.18% (-0.03)
May 06, 20192019 (Q3)
- / 0.39
0.46-15.22% (-0.07)
Aug 27, 20192019 (Q4)
- / 0.33
0.46-28.26% (-0.13)
Nov 04, 20192020 (Q1)
- / 0.19
0.39-51.28% (-0.20)
Feb 03, 20202020 (Q2)
- / 0.34
0.41-17.07% (-0.07)
May 07, 20202020 (Q3)
- / 0.38
0.39-2.56% (-0.01)
Aug 26, 20202020 (Q4)
- / 0.17
0.33-48.48% (-0.16)
Nov 04, 20202021 (Q1)
- / 0.27
0.1942.11% (+0.08)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

PAHC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2024$23.09$23.50+1.78%
Aug 28, 2024$20.68$21.34+3.19%
May 08, 2024$16.96$17.47+3.01%
Feb 07, 2024$10.44$11.21+7.38%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Phibro Animal Health (PAHC) report earnings?
Phibro Animal Health (PAHC) is schdueled to report earning on Feb 05, 2025, TBA Not Confirmed.
    What is Phibro Animal Health (PAHC) earnings time?
    Phibro Animal Health (PAHC) earnings time is at Feb 05, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is PAHC EPS forecast?
          PAHC EPS forecast for the fiscal quarter 2025 (Q2) is 0.43.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis